We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bristol-Myers Squibb Pharmaceuticals uc

Plaza 254, Blanchardstown Corporate Park 2, Ballycoolin, Dublin 15, D15 T867, Ireland
Telephone: 01 483 3625
Medical Information Direct Line: 1 800 749 749
Medical Information e-mail: medical.information@bms.com
Summary of Product Characteristics last updated on medicines.ie: 6/19/2017
SPC Sprycel 20mg, 50mg, 70mg and 100mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 6/19/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   09-Jun-2017
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company


4.8     Undesirable effects

        Table 2:           Tabulated summary of adverse reactions

Skin and subcutaneous tissue disorders

Very common

skin rashe


alopecia, dermatitis (including eczema), pruritus, acne, dry skin, urticaria, hyperhidrosis